Strides Arcolab Ltd, a leading specialty pharmaceutical formulations company, has commissioned its state-of-the-art global pharmaceutical research center. The R&D centre was inaugurated by chairman & managing director of Export-Import Bank of India, T C Venkat Subramanian, on March 26. The new R&D facility- Star Technology and Research Centre (STAR) is spread over 50,000 square feet with an investment of Rs 18 crore will spearhead the research activities for company's global partners. The centre will also focus on research in global diseases like HIV, Tuberculosis and Malaria.

All research facilities of the company will be consolidated in the new premises. The centre has been designed to global standards and already employs 200 scientists. The R&D scientific pool is being further enhanced to meet the challenges of the company's global partners. The R&D centre is equipped with latest equipment matching those of the global centres.

Speaking on the occasion, Arun Kumar, Group CEO, Strides Arcolab said, "The new R&D Centre will herald a new chapter in the history of the company. It is further reflection of our belief in setting up global scale facilities. The centre will provide significant impetus to our research strategy which is focused on NDDS and non infringing process besides proprietary matrix technology. We already are working with 10 global pharma clients in these areas."

The R&D Centre will develop patentable technology and non-infringing formulations across dosage forms. It will also work on areas like analytical method development, conducting stability studies to manufacturing clinical supplies for proof of concept studies.